Cvs_caremark Prior Authorization Lookup
Latest Cvs_caremark prior authorization updates25
- Prior AuthClinical/Medical PolicyInhaled Corticosteroids Medical NecessityThis policy governs medical-necessity and prior-authorization coverage for specified inhaled corticosteroids, including brand and generic products and all dosage forms and strengths unless otherwise stated. It applies to providers requesting coverage for asthma maintenance treatment and the specified compendial use of Flovent HFA for eosinophilic esophagitis.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInitial Prior Authorization AmphetaminesThis policy governs initial prior authorization for prescription amphetamine, amphetamine-dextroamphetamine, dextroamphetamine, lisdexamfetamine, and methamphetamine products, including FDA-approved indications and age-related limitations.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInitial Prior Authorization Tacrolimus OintmentThis policy governs initial and continuation prior authorization for tacrolimus ointment, including 0.03% and 0.1% strengths, for atopic dermatitis, psoriasis, and vitiligo. It applies to requests for both generic tacrolimus ointment and all dosage forms and strengths referenced by the document.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInitial Prior Authorization Terbinafine TabletsThis policy governs initial prior authorization coverage for generic terbinafine tablets used to treat onychomycosis, tinea capitis, tinea corporis, and tinea cruris.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInitial Prior Authorization Topical RetinoidsInitial and continuation prior authorization for prescription topical retinoid products, including tretinoin and clindamycin/tretinoin products, for acne vulgaris and keratosis follicularis (Darier disease).All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInitial Prior Authorization with Quantity Limit OpzeluraThis policy governs initial and continuation prior authorization for Opzelura cream, including coverage criteria for atopic dermatitis and nonsegmental vitiligo and applicable quantity limits. It applies to adult and pediatric patients meeting the condition-specific age, clinical response, body surface area, and treatment-use requirements.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInitial Prior Authorization with Quantity Limit Qsymia Weight Loss ManagementThis policy governs initial and continuation prior authorization, dose escalation, and quantity limits for Qsymia (phentermine/topiramate extended-release) used with diet and physical activity for weight reduction or long-term maintenance in adults and patients aged 12 years and older who meet specified eligibility criteria.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInitial Prior Authorization with Quantity Limit Voltaren GelThis policy governs initial and continuation prior authorization, including quantity limits, for diclofenac sodium topical gel 1% and Voltaren Gel OTC. Coverage applies to osteoarthritis pain in joints amenable to topical treatment when specified clinical criteria are met.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInitial Prior Authorization with Quantity Limit Wegovy Weight Loss ManagementThis policy governs initial and continuation prior authorization, quantity limits, and approval durations for Wegovy products used for chronic weight management, cardiovascular risk reduction, or noncirrhotic MASH in adults and eligible adolescents, subject to indication-specific criteria and product restrictions.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInitial Prior Authorization with Quantity Limit Zepbound Weight Loss ManagementThis policy governs initial and continuation prior authorization, quantity limits, and approval durations for Zepbound (tirzepatide) in adults with obesity or overweight-related weight management needs and adults with obesity and moderate to severe obstructive sleep apnea. Coverage requires specified clinical criteria, documentation, reduced-calorie diet, and increased physical activity.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInitial Prior Authorization with Quantity Limit: Ciclopirox Topical Solution 8 PercentThis policy governs initial prior authorization and quantity limits for ciclopirox topical solution 8% used to treat qualifying onychomycosis.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInitial Prior Authorization with Quantity — Disposable Insulin PumpsThis policy governs initial prior authorization and quantity limits for pharmacy-dispensed disposable insulin pumps, including Omnipod, Twiist, and V-Go products, for patients with diabetes.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyInsomnia Agents Post-Limit Prior Authorization CriteriaThis policy governs post-limit prior authorization for specified prescription insomnia agents, including initial and continuation therapy requirements and quantity limits. It applies to providers requesting coverage for patients treated for insomnia.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyNon-covered Drug Medical NecessityThis policy governs prior authorization for requested drugs classified as non-covered under CVS Caremark medical necessity criteria. Coverage may be authorized when the patient cannot use formulary alternatives, the requested use is supported by FDA labeling or accepted compendia, and the dose and quantity are appropriate.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyPost Limit Prior Authorization Proton Pump InhibitorsThis policy governs coverage of additional quantities of specified proton pump inhibitors after the plan quantity limit is reached. Providers must document an accepted gastrointestinal indication or high risk for gastrointestinal adverse events for approval.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyPrior Authorization Criteria for GLP-1 and GIP/GLP-1 Receptor AgonistsThis policy governs prescription coverage and prior authorization for listed GLP-1 receptor agonists and tirzepatide, primarily for type 2 diabetes mellitus, including automated claim screening and clinical review when screening criteria are not met.All cvs_caremark updates
- Prior AuthClinical/Medical PolicySpecialty Guideline Management BimzelxCoverage and prior authorization requirements for Bimzelx in adult members with moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, or hidradenitis suppurativa.All cvs_caremark updates
- Prior AuthClinical/Medical PolicySpecialty Guideline Management CosentyxThis policy governs prior authorization coverage for Cosentyx (secukinumab) for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, enthesitis-related arthritis, and hidradenitis suppurativa when applicable age, prior-treatment, clinical-response, prescriber, and documentation requirements are met.All cvs_caremark updates
- Prior AuthClinical/Medical PolicySpecialty Guideline Management HyaluronatesCoverage and prior authorization for listed hyaluronate products used to treat pain from osteoarthritis of the knee when diagnostic, treatment history, clinical symptom, and continuation criteria are met.All cvs_caremark updates
- Prior AuthClinical/Medical PolicySpecialty Guideline Management Otezla-Otezla XRThis policy governs prior authorization for Otezla (apremilast) and Otezla XR (apremilast extended-release) for plaque psoriasis, psoriatic arthritis, Behcet's disease, and immune checkpoint inhibitor-related toxicity. It applies to members whose requested therapy meets the applicable indication, prior-treatment, clinical-response, documentation, and prescriber-specialty requirements.All cvs_caremark updates
- Prior AuthClinical/Medical PolicySpecialty Guideline Management Prolia and BiosimilarsThis policy governs specialty guideline management and prior authorization for Prolia (denosumab) and listed denosumab biosimilars for osteoporosis, glucocorticoid-induced osteoporosis, cancer-therapy-related bone loss, and rheumatoid arthritis when applicable coverage criteria are met.All cvs_caremark updates
- Prior AuthClinical/Medical PolicySpecialty Guideline Management SpravatoThis policy governs prior authorization and continuation coverage for Spravato (esketamine) in adults with treatment-resistant depression or major depressive disorder with acute suicidal ideation or behavior, subject to clinical criteria, documentation, provider supervision, monitoring, and REMS-compliant administration.All cvs_caremark updates
- Prior AuthClinical/Medical PolicySpecialty Guideline Management TaltzThis policy governs prior authorization and continuation coverage for Taltz (ixekizumab) used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. It applies to members seeking initial or renewal authorization and establishes clinical criteria, documentation, prescriber specialty, and safety requirements.All cvs_caremark updates
- Prior AuthClinical/Medical PolicySpecialty Guideline Management TremfyaThis policy governs prior authorization and continuation of Tremfya for plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease, subject to specified clinical, treatment, documentation, and prescriber requirements.All cvs_caremark updates
- Prior AuthClinical/Medical PolicyStrattera (atomoxetine HCl) Prior AuthorizationThis policy governs initial and continuation prior authorization for Strattera and generic atomoxetine HCl in all dosage forms and strengths. Coverage applies to patients being treated for ADHD or ADD when the specified diagnostic documentation, clinical monitoring, and continuation criteria are met.All cvs_caremark updates
Tool Description
Search Cvs_caremarkprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Billing Code Reimbursement RatesBuild a reimbursement rate report across any mix of billing codes and states, comparing commercial payers against Medicare.
- Payer Comparison DashboardPick 2-5 payers to compare market share, premium, and membership by region, all at once.
- Facility Comparison DashboardPick 2-6 hospital facility types (or add a specific hospital) to compare facility count, revenue, net income, and Medicare/Medicaid payer mix by region, all at once.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.